A 2D LC-MS/MS Strategy for Reliable Detection of 10-ppm Level Residual Host Cell Proteins in Therapeutic Antibodies.

Methodologies employing LC-MS/MS have been increasingly used for characterization and identification of residual host cell proteins (HCPs) in biopharmaceutical products to ensure their consistent product quality and safety for patients. To improve the sensitivity and reliability for HCP detection, we developed a high pH-low pH two-dimensional reversed phase LC-MS/MS approach in conjunction with offline fraction concatenation. Proof-of -concept was established using a model in which seven proteins spanning a size range of 29-78 kDa are spiked into a purified antibody product to simulate the presence of low-level HCPs. By incorporating a tandem column configuration and a shallow gradient through the second-dimension, all seven proteins were consistently identified at 10 ppm with 100% success rate following LC-MS/MS analysis of six concatenated fractions across multiple analysts, column lots and injection loads. Using the more complex Universal Proteomic Standard 1 (UPS-1) as an HCP model, positive identification was consistently achieved for 19 of the 22 proteins in 8-12 ppm range (10 ppm ±20%). For the first time, we demonstrate an effective LC-MS/MS strategy that not only has high sensitivity but also high reliability for HCP detection. The method performance has high impact on pharmaceutical company practices in using advanced LC-MS/MS technology to ensure product quality and patient safety.

[1]  Christine Carapito,et al.  Dual Data-Independent Acquisition Approach Combining Global HCP Profiling and Absolute Quantification of Key Impurities during Bioprocess Development. , 2018, Analytical chemistry.

[2]  Paul D Piehowski,et al.  High-resolution ultrahigh-pressure long column reversed-phase liquid chromatography for top-down proteomics. , 2017, Journal of chromatography. A.

[3]  Z. Li,et al.  Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data with Parallel Reaction Monitoring Verification. , 2017, Analytical chemistry.

[4]  Lihua Huang,et al.  A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies. , 2017, Analytical chemistry.

[5]  Donald E Walker,et al.  A modular and adaptive mass spectrometry-based platform for support of bioprocess development toward optimal host cell protein clearance , 2017, mAbs.

[6]  Ronald J. Moore,et al.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.

[7]  Nathan E Lewis,et al.  Elucidation of the CHO Super-Ome (CHO-SO) by Proteoinformatics. , 2015, Journal of proteome research.

[8]  Weibin Chen,et al.  Enhanced Detection of Low-Abundance Host Cell Protein Impurities in High-Purity Monoclonal Antibodies Down to 1 ppm Using Ion Mobility Mass Spectrometry Coupled with Multidimensional Liquid Chromatography. , 2015, Analytical chemistry.

[9]  A. Farrell,et al.  Quantitative host cell protein analysis using two dimensional data independent LC-MS(E). , 2015, Analytical chemistry.

[10]  V. Farutin,et al.  Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis , 2015, mAbs.

[11]  J. Zhu-Shimoni,et al.  Host cell protein testing by ELISAs and the use of orthogonal methods , 2014, Biotechnology and bioengineering.

[12]  V. Reisinger,et al.  A mass spectrometry-based approach to host cell protein identification and its application in a comparability exercise. , 2014, Analytical biochemistry.

[13]  Ronald J Moore,et al.  Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels* , 2014, Molecular & Cellular Proteomics.

[14]  Art Hewig,et al.  Comprehensive tracking of host cell proteins during monoclonal antibody purifications using mass spectrometry , 2014, mAbs.

[15]  M. Mølhøj,et al.  Identification and Monitoring of Host Cell Proteins by Mass Spectrometry Combined with High Performance Immunochemistry Testing , 2013, PloS one.

[16]  Alois Jungbauer,et al.  Harnessing Candida tenuis and Pichia stipitis in whole‐cell bioreductions of o‐chloroacetophenone: Stereoselectivity, cell activity, in situ substrate supply and product removal , 2013, Biotechnology journal.

[17]  G. C. Flynn,et al.  Identification and quantification of host cell protein impurities in biotherapeutics using mass spectrometry. , 2012, Analytical biochemistry.

[18]  Richard D. Smith,et al.  High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis , 2012, Expert review of proteomics.

[19]  Alex Xenopoulos,et al.  Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry , 2012, mAbs.

[20]  Ronald J. Moore,et al.  Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells , 2011, Proteomics.

[21]  W. Ens,et al.  Practical implementation of 2D HPLC scheme with accurate peptide retention prediction in both dimensions for high-throughput bottom-up proteomics. , 2008, Analytical chemistry.

[22]  Michael Rubacha,et al.  Demonstration of Robust Host Cell Protein Clearance in Biopharmaceutical Downstream Processes , 2008, Biotechnology progress.

[23]  E. Heinzle,et al.  Two-dimensional reversed-phase x ion-pair reversed-phase HPLC: an alternative approach to high-resolution peptide separation for shotgun proteome analysis. , 2007, Journal of proteome research.

[24]  J. Gebler,et al.  Orthogonality of separation in two-dimensional liquid chromatography. , 2005, Analytical chemistry.

[25]  Ronald J. Moore,et al.  Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. , 2005, Analytical chemistry.